Efficacy and Safety of Empagliflozin in Type 1 Diabetes Mellitus Patients: A Systematic Review
(Endocrinol Res Pract 2021; 25: 426-438) DOI: 10.25179/tjem.2021-83912
(Endocrinol Res Pract 2021; 25: 426-438) DOI: 10.25179/tjem.2021-83912
Mustafa Kanat, Nadir Goksugur, Ali Haydar Parlak
(Endocrinol Res Pract 2005; 9: 125-127)